


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-0.58%
-1.05%
-2.43%
+27.27%
CVS
CVS Health
$86.86

Login to see CVS Health (CVS) Stock IQ rating
Get instant clarity on whether to Buy, Hold, or Avoid.
Strengths

Earnings are forecast to grow

Trading below its fair value

Outperform the market

Upgraded on attractively valued
CVS Price Performance
$79.33 (+9.49%)
$75.7 (+14.74%)
$80.83 (+7.46%)
$62.11 (+39.85%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Reported a strong earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
Trading below its fair value
Outperform the market
CVS Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
CVS Street Sentiment is bullish and have positive views on the near-term outlook
CVS has Low risk level

Sentiments overview associated with events and the stock performance
Recent Upgrades and Downgrades
Mar 24, 2026
Upgrade
Outperform
Bernstein
Mar 23, 2026
Upgrade
Outperform
Bernstein
Dec 18, 2025
Reiterate
Overweight
JP Morgan
Apr 16, 2026
Reiterate
Buy
UBS
Nov 14, 2025
Reiterate
Overweight
Wells Fargo
What is CVS current stock price?
What are CVS stock strengths?
What is CVS Risk Level?
What is CVS market cap and volume?
What is CVS current Stock IQ?
Should I buy CVS stock right now?
Is CVS a Strong Buy right now?
What does a 'Strong Buy' rating mean for CVS?
What does a 'Strong Sell' rating mean for CVS?
What factors influence CVS's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
CVS
CVS Health
Current Price
$86.86

CVS Price Performance
$79.33 (+9.49%)
$75.7 (+14.74%)
$80.83 (+7.46%)
$62.11 (+39.85%)
CVS Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Reported a strong earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
Trading below its fair value
Outperform the market
CVS Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
CVS Street Sentiment is bullish and have positive views on the near-term outlook
CVS has Low risk level

Overall Wall Street Rating
CVS Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Trading below its fair value

Outperform the market

Upgraded on attractively valued
CVS Trading Signals
CVS is now at $86.86, up +7.65% from $80.69. This rapid movement warrants attention.
CVS at $86.86 is within 2.00% of its 52-week high of $88.63. This proximity suggests potential breakout zone ahead.
CVS has positive earnings news: Beat Estimates. CVS Boosts Outlook for 2026 After Aetna Profits Increase. CVS Health Corp. raised its earnings outlook for the year after profit and revenue in the fi...
CVS has positive earnings news: Beat Estimates. CVS Healths Lower Medical Cost Ratio Lift Profit Outlook. CVS Health Corp . (NYSE: CVS ) stock is surging on Wednesday after upbeat first-quarte...
CVS has positive earnings news: Strong Earnings. CVS Health Q1 2026 slides: strong results drive raised guidance....
CVS has negative earnings news: Weak Earnings. Earnings Scheduled For May 6 2026. Companies Reporting Before The Bell . Deluxe (NYSE: DLX ) is expected to report quarterly earnings at $0.89 per ...
CVS has positive earnings news: Strong Earnings. CVS HEALTH CORPORATION REPORTS STRONG FIRST QUARTER 2026 RESULTS AND RAISES FULL-YEAR 2026 GUIDANCE. First quarter total revenues increased to $100.4 ...
CVS beat earnings expectations. CVS Boosts Outlook for 2026 After Aetna Profits Increase. CVS Health Corp. raised its earnings outlook for the year after profit and revenue in the fi...
CVS beat earnings expectations. CVS Healths Lower Medical Cost Ratio Lift Profit Outlook. CVS Health Corp . (NYSE: CVS ) stock is surging on Wednesday after upbeat first-quarte...
CVS opened with a gap up of 5.97% (prev close $80.69, open $85.51)
CVS showing early bullish trend, price above MA20 (77.69) and MA20 above MA50 (77.01)
CVS RSI surged 12 points in one day (RSI: 57.5 to 69.5)
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
was the undisputed star of the session, surging roughly 16% on a blowout earnings report that sent the broader semiconductor sector into rally mode. Revenue and guidance both cleared estimates by a wide margin, CEO Lisa Su...
Read More